Lisinopril and Hydrochlorothiazide
- Product NDC
- 50436-7000
- 11-digit product format
- 504367000
- Labeler code
- 50436
- Product ID
- 50436-7000_d6e4ff81-2bdc-4cd0-be12-10326ef0087f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Unit Dose Services
- Application
- ANDA077912
- Marketing category
- ANDA
- Marketing start
- 2006-10-04
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Active strength
- 13 mg/1; mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 0J48LPH2TH | HYDROCHLOROTHIAZIDE | 58-93-5 | HYDROCHLOROTHIAZIDE |
| E7199S1YWR | LISINOPRIL | 83915-83-7 | LISINOPRIL |